Fischer Medical Ventures Ltd announces unaudited Q2 and H1 FY 2026-27 financial results
Fischer Medical Ventures · Healthcare Equipment & Supplies
Key highlights
- Board approved allotment of 4,54,210 equity shares at ₹23.40/share on 17 August 2026 upon conversion of convertible warrants, raising ₹7.97 crore
- Multiple allotments of equity shares in August 2026 totaling over ₹77 crore upon conversion of convertible warrants held by promoters and non-promoters
- Revised comparative figures for Q2 and H1 FY 2025-26 due to audit adjustments in foreign subsidiaries; revisions did not impact overall annual profit or reserves
Original filing
Board Meeting Outcome for Approval Of Financial Results For The Quarter And Half Year Ended 30Th Sept 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Fischer Medical Ventures
Other financial results filings this fortnight
- Financial resultsLords Mark IndustriesLord's Mark Industries Ltd submits revised Q2 & H1 FY2026 financial results
- Financial resultsMidwest EnergyMidwest Energy Limited approves Q2 FY27 results, subsidiary incorporation, share allotment
- Financial resultsBalu Forge IndustriesBalu Forge approves Q2 FY27 results and proposes preferential issue of warrants
- Financial resultsVishnu Prakash R PungliaVishnu Prakash R Punglia Ltd reports Q2 & H1 FY 2026-27 unaudited financials
- Financial resultsAshok LeylandAshok Leyland Limited announces Q2 and H1 FY 2026-27 results and interim dividend
- Financial resultsKS Smart TechnlogiesKS Smart Technologies reports Q2 & H1 FY27 results, approves subsidiary merger
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Poly MedicureGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.